Drugs
-
Fluvoxamine Maleate Information
Fluvoxamine maleate is included in the class of drugs called selective serotonin reuptake inhibitors (SSRIs). This class of drugs is used to treat depression, anxiety, and other mood disorders.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program, using the contact information at the bottom of this page.
-
Related Information
FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies
12/14/2011Antidepressant Use in Children, Adolescents, and Adults
5/2/2007Understanding Antidepressant Medications
FDA consumer updateInformation for Healthcare Professionals: Fluvoxamine - Selective Serotonin Reuptake Inhibitors (SSRIs)
7/2006Public Health Advisory: Treatment Challenges of Depression in Pregnancy and the Possibility of Persistent Pulmonary Hypertension in Newborns
7/2006Information for Healthcare Professionals: Selective Serotonin Reuptake Inhibitors (SSRIs), Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), 5-Hydroxytryptamine Receptor Agonists (Triptans)
7/2006Public Health Advisory - Combined Use of 5-Hydroxytryptamine Receptor Agonists (Triptans), Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) May Result in Life-threatening Serotonin Syndrome
7/2006Fluvoxamine Maleate Historical Information
FDA Alert issued 7/2005
-
-
Labeling and Regulatory History from Drugs@FDA
-
-
-
